Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Oct 25, 2019
Product Development
Lykera takes aim at aggressive cancers by targeting pre-metastatic niche
Lykera's mAbs target S100 proteins implicated in driving cancer metastases
BioCentury | Feb 27, 2019
Finance
Calypso finds its rhythm
How rising interest in IL-15 helped six-year-old Calypso close its series A
BioCentury | Sep 9, 2017
Strategy
Some of the parts
Can Gilead apply its combination chops to make Kite CAR Ts work in solid tumors?
Items per page:
1 - 10 of 52